(Updates RIC in 1st bullet) ** JP Morgan changes prior call on GlaxoSmithKline and lifts British drugmaker's stock to "neutral" ** Earnings expectations now look achievable, pipeline review suggests upcoming R&D day has positive risk/reward and stock's 6-pct dividend yield provides
Read more(ShareCast News) - GlaxoSmithKline has submitted a regulatory application to the European Medicines Agency for its antiseptic chlorhexidine gel for the prevention of umbilical cord infections in newborn babies. Glaxo said the EMA has granted the application accelerated assessment, a process open to
Read more* Trial to test safety and immunogenicity of Ebola vaccine * J&J working with Bavarian Nordic on prime-boost vaccine (Adds executive comment, link to story on Ebola nurse) By Ben Hirschler Oct 9 (Reuters) - Johnson & Johnson has begun a clinical trial of a two-shot Ebola vacci
Read moreBy Kate Kelland, Health and Science Correspondent LONDON, Oct 8 (Reuters) - Scientists still don't know if two commonly-used flu drugs -- Roche's Tamiflu and GlaxoSmithKline's Relenza -- really work in seasonal or pandemic flu outbreaks and say robust clinical trials are urgently needed to
Read more(ShareCast News) - Glencore nearly bounced to pre-slump levels on Thursday, and director John Mack showed investors he's still backing the mining company. Shares in the FTSE 100-listed company dropped dramatically on Monday after Investec warned the stock holds little value for shareholders. But Jo
Read more* WHO recommendation means 37 million should be on treatment * Early use of drugs extends lives, protects partners * MSF welcomes move but warns costs will soar (Adds details on costs) By Stephanie Nebehay GENEVA, Sept 30 (Reuters) - Everyone with HIV should be given ant
Read moreBy Julie Steenhuysen CHICAGO, Sept 30 (Reuters) - Berg, a private company that uses artificial intelligence to discover new drugs and diagnostics, will help England's national genomics project mine DNA and health data from thousands of British citizens for potential drug targets. Berg
Read more* Scheme initially targets Kenya, Ethiopia, Vietnam * Treatments for hypertension, diabetes, breast cancer * Company plans eventually to roll out to 30 countries (Adds details on cost of medicines, spike in diabetes cases in Vietnam) By John Miller ZURICH, Sept 24 (Reute
Read more